SPY336.84+4.47 1.34%
DIA278.82+4.40 1.60%
IXIC11,254.42+169.17 1.53%

Raymond James Upgrades VBI Vaccines to Strong Buy, Raises Price Target to $9

Raymond James upgrades VBI Vaccines (NASDAQ:VBIV) from Outperform to Strong Buy and raises the price target from $8 to $9.

 · 
Raymond James upgrades VBI Vaccines (NASDAQ:VBIV) from Outperform to Strong Buy and raises the price target from $8 to $9.